State Street® Health Care Select Sector SPDR® ETF XLV

Medalist Rating as of | See State Street Investment Hub

Morningstar’s Analysis XLV

Will XLV outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

State Street®HlthCrSelSectSPDR®ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings XLV

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 60.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

16.13 7B
Healthcare

Johnson & Johnson

10.61 4B
Healthcare

AbbVie Inc

7.52 3B
Healthcare

UnitedHealth Group Inc

6.62 3B
Healthcare

Merck & Co Inc

5.23 2B
Healthcare

Amgen Inc

3.36 1B
Healthcare

Thermo Fisher Scientific Inc

3.36 1B
Healthcare

Abbott Laboratories

2.81 1B
Healthcare

Gilead Sciences Inc

2.77 1B
Healthcare

Intuitive Surgical Inc

2.47 1B
Healthcare

Sponsor Center